University Multiprofile Hospital for Active Treatment Aleksandrovska EAD

Sofia 1431

1 studies enrolling now · 10 studies all time

What they study most

Alzheimer's Disease, CIDP, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Spontaneous Urticaria, Cystic Fibrosis, Multiple Sclerosis, Muscular Dystrophy, Duchenne, Neuromyelitis Optica Spectrum Disorder, Partial Epilepsy, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP — Recruiting now
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed
• Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
• Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease — Completed
• A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy — Stopped early
• Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) — Completed
• Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis — Stopped early